Bristol-Myers Squibb Company
Viés de alta

$BMY Golden Cross / Ascending Triangle

BMY 50d/200d ema Golden Cross / Bullish Ascending Triangle

Golden Cross/Break-out of Triangle appears imminent.

Near term target - $64



Note: Informational analysis, not investment advice.

Aviso legal